In BCR/ABL+CML cells, activated Src may induce the phosphorylation of BCR/ABL at Tyr89 and Tyr245 and further increase the tyrosine kinase activity of BCR/ABL [37]. This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.